Cargando…

Venous thromboembolic events in glioblastoma patients: An epidemiological study

BACKGROUND AND PURPOSE: Venous thromboembolic events (VTEs) are a major complication in cancer patients, and therefore, also in brain cancer patients, anticoagulants are considered appropriate in the treatment of VTEs. METHODS: Frequency, risk factors, and treatment of VTEs, as well as associated co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisele, Amanda, Seystahl, Katharina, Rushing, Elisabeth J., Roth, Patrick, Le Rhun, Emilie, Weller, Michael, Gramatzki, Dorothee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Neuro‐oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543144/ https://www.ncbi.nlm.nih.gov/pubmed/35545894 http://dx.doi.org/10.1111/ene.15404

Ejemplares similares

NEIM-13 THE PROGNOSTIC ROLE OF VENTRICULAR SIZE AND ITS DYNAMICS IN PATIENTS WITH LEPTOMENINGEAL METASTASIS FROM SOLID TUMORS
por: Le Rhun, Emilie, et al.
Publicado: (2023)

MLTI-19. VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH BRAIN METASTASES: THE PICOS SCORE
por: Wolpert, Fabian, et al.
Publicado: (2019)

Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Immune-checkpoint inhibitors for glioblastoma: what have we learned?
por: Omuro, Antonio
Publicado: (2022)

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial
por: Vils, Alex, et al.
Publicado: (2021)

Transforming growth factor-β pathway activity in glioblastoma
por: Frei, Karl, et al.
Publicado: (2015)

Risk of Venous Thromboembolism in Glioblastoma Patients
por: Lim, Gerald, et al.
Publicado: (2018)

Neurologic adverse events of cancer immunotherapy
por: de Brito, Marcelo Houat
Publicado: (2022)

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022)

Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study
por: She, Lei, et al.
Publicado: (2022)

Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo
por: Szabo, Emese, et al.
Publicado: (2016)

Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
por: Le Rhun, Emilie, et al.
Publicado: (2013)

The future of high-grade glioma: Where we are and where are we going
por: Rhun, Emilie Le, et al.
Publicado: (2015)

Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study)
por: Booth, Thomas C., et al.
Publicado: (2020)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling
por: Yu, Xiaojun, et al.
Publicado: (2023)

Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study
por: Garnier, Louis, et al.
Publicado: (2022)

A peculiar case of pure intraventricular glioblastoma
por: Zanuttini, Luca, et al.
Publicado: (2023)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

SyMRI detects delayed myelination in preterm neonates
por: Schmidbauer, Victor, et al.
Publicado: (2019)

A risk model for prediction of diagnosis of cancer after ischemic stroke
por: Seystahl, Katharina, et al.
Publicado: (2023)

Recurrent Glioblastoma: Where we stand
por: Roy, Sanjoy, et al.
Publicado: (2015)

Molecular imaging of 1p/19q deletion in oligodendroglial tumours with (11)C-methionine positron emission tomography
por: Iwadate, Yasuo, et al.
Publicado: (2016)

Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
por: Johnson, Adrienne, et al.
Publicado: (2017)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Challenges Conveying Clinical Equipoise and Exploring Patient Treatment Preferences in an Oncology Trial Comparing Active Monitoring with Radiotherapy (ROAM/EORTC 1308)
por: Sherratt, Frances C., et al.
Publicado: (2020)

Integration of Tumor‐Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
por: Wang, Yuefeng, et al.
Publicado: (2019)

The use of eye‐movement recording in patients with anti‐Hu antibody–associated paraneoplastic neurological syndromes to objectively determine extent and course of disease
por: Janssen, Malou, et al.
Publicado: (2021)

The APOE ε4 allele in relation to pre‐ and postsurgical cognitive functioning of patients with primary brain tumors
por: Butterbrod, Elke, et al.
Publicado: (2021)

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study
por: Hoisnard, Léa, et al.
Publicado: (2022)

Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
por: Park, Susanna B, et al.
Publicado: (2023)

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States
por: Smyth, Emily Nash, et al.
Publicado: (2023)

The epidemiology of venous thromboembolism
por: Heit, John A., et al.
Publicado: (2016)

The splenial angle: a novel radiological index for idiopathic normal pressure hydrocephalus
por: Chan, Ling Ling, et al.
Publicado: (2021)

A tumor-promoting role for soluble TβRIII in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML
por: Alleg, Manel, et al.
Publicado: (2020)

Venous air embolisms and sitting position in Helsinki pineal region surgery
por: Choque-Velasquez, Joham, et al.
Publicado: (2018)

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02
por: Lohmann, Birthe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p4n1e4hdp2poluf7rhbovt1b39